D.E. Shaw & Co’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

D.E. Shaw & Co’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,359	Closed	-$2K	–	4101
2018 Q4	$2K	Sell	13,359 -155,505	-92%	-$102K	﹤0.01%	3720
2018 Q3	$287K	Buy	+168,864	New	+$302K	﹤0.01%	3378
2018 Q1	–	Sell	-28,964	Closed	-$65K	–	3918
2017 Q4	$65K	Sell	28,964 -6,385	-18%	-$15.9K	﹤0.01%	3520
2017 Q3	$103K	Sell	35,349 -11,310	-24%	-$38.6K	﹤0.01%	3364
2017 Q2	$208K	Sell	46,659 -20,486	-31%	-$84.5K	﹤0.01%	3180
2017 Q1	$313K	Sell	67,145 -149,093	-69%	-$865K	﹤0.01%	2952
2016 Q4	$1.32M	Buy	216,238 +28,027	+15%	+$147K	﹤0.01%	2293
2016 Q3	$1.04M	Buy	188,211 +109,736	+140%	+$514K	﹤0.01%	2362
2016 Q2	$298K	Buy	+78,475	New	+$266K	﹤0.01%	3020

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

D.E. Shaw & Co's SGYP Position: Q1 2019 in Review

D.E. Shaw & Co sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 13,359 shares — an estimated $2K sold.

D.E. Shaw & Co first reported a position in SGYP in Q2 2016 and held it in 9 quarters. The position peaked at $1.32M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

D.E. Shaw & Co reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
D.E. Shaw & Co sold 13,359 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
D.E. Shaw & Co first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 9 quarters.
D.E. Shaw & Co's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.32M in Q4 2016.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.